Rodenburg, Lisa W.
Metzemaekers, Mieke
van der Windt, Isabelle S.
Smits, Shannon M. A.
den Hertog-Oosterhoff, Loes A.
Kruisselbrink, Evelien
Brunsveld, Jesse E.
Michel, Sabine
de Winter-de Groot, Karin M.
van der Ent, Cornelis K.
Stadhouders, Ralph
Beekman, Jeffrey M.
Amatngalim, Gimano D.
Funding for this research was provided by:
Cystic Fibrosis Trust (SRC 013)
European Molecular Biology Organization (ALTF 992-2021)
Nederlandse Cystic Fibrosis Stichting (HIT-CF)
Article History
Received: 18 April 2023
Accepted: 17 October 2023
First Online: 30 October 2023
Competing interests
: J.M.B. has a patent granted (10006904) related to CFTR function measurements in organoids and received personal fees from HUB/Royal Dutch academy of sciences, during the conduct of the study; nonfinancial support from Vertex Pharmaceuticals and personal fees and nonfinancial support from Proteostasis Therapeutics, outside the submitted work. C.K.v.d.E. reports grants from GSK, Nutricia, TEVA, Gilead, Vertex, ProQR, Proteostasis, Galapagos NV, Eloxx pharmaceuticals, outside the submitted work; In addition, C.K.v.d.E. has a patent related to CFTR function measurements in organoids (10006904) with royalties paid. The other authors declare no potential conflict of interest.